Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage

T1D: Debunking the Age Myth

An infographic describing the prevalence of and challenges faced in diagnosing adult-onset T1D 

IMD: Why Every Hour Matters in Meningococcal Disease Management

Learn about the rapid progression of Invasive Meningococcal Disease (IMD), its clinical manifestations, and why early diagnosis is crucial for patient survival.

IMD Complications & Family Burden: Understanding the Multi-dimensional Impact

Explore the comprehensive impact of Invasive Meningococcal Disease (IMD), including family burden, survivor complications, and quality of life effects. Learn about neurological and non-neurological complications affecting IMD survivors.

Nuevas Fronteras en Diabetes Tipo 1

Polyp Gossip Episode 5: Personalized Care for CRSwNP: Finding What Works Best for You

In this episode of Polyp Gossip, we explore the power of personalized care in CRSwNP. From symptoms to patient profiles, our experts discuss how tailored treatment strategies can lead to better outcomes and improved quality of life. Tune in to discover what "finding what works best for you" really means in today's evolving care landscape.

LixiLan-G Çalışması: GLP-1 RA Tedavisiyle Yetersiz Kontrol Sağlanan T2DM Hastalarında iGlarLixi’ye Geçişin Etkililiği ve Güvenliliği

¿Cómo diferenciar Diabetes Tipo 1 de Diabetes Tipo 2 en Adultos?

Se estima que hasta el 40% de los adultos mayores de 30 años con diabetes tipo 1 podrían haberse diagnosticado erróneamente con diabetes tipo 2 (1). La diabetes tipo 1 y la diabetes tipo 2 son enfermedades heterogéneas en las que la presentación clínica y la progresión de la enfermedad pueden variar considerablemente. Uno de los desafíos fundamentales con el diagnóstico erróneo de diabetes tipo 1 en adultos es la suposición de que un adulto con diabetes tendría diabetes tipo 2.

Living With ITP